A presentation on recent research into herpesvirus type 1 (EHV-1) vaccines was given by Klaus Osterrieder, DVM, DVM Habilitation (a German equivalent to a PhD), associate professor of virology in the College of Veterinary Medicine at Cornell the evening of March 26 in Lexington, Ky. His discussion was on EHV-1, Thoughts About the Virus, the Disease, and Ways of Prevention.

Osterrieder asked the question of his audience: Why do a pedestrian vaccination study using a vaccine that has been around since the 1960s?

His answer: Because there was Findlay and because we appear to see the neurological disease more often.

An outbreak of neurologic EHV-1 at the University of Findlay in Ohio in early 2004 was discussed at a meeting in Italy that Osterrieder attended. At that meeting, researchers from The Ohio State University discussed the outbreak, including detailing the severity and type of neurologic signs based on how the horses had been vaccinated